■ Microbiome specialized company ‘HME Healthcare’ selected as ‘investment option guarantee’ company worth 600 million won
■ Recognized for future growth value… Selected through the Credit Guarantee Fund Innovative Startup Support Program
■ Gyeonggi Creative Economy Innovation Center childcare company possesses core microbiome big data analysis technology
HME Co., Ltd. (CEO Park Tae-jin) Healthcare, a microbiome specialist company, announced on the 27th that it was recently selected as an ‘investment option guarantee’ company worth 600 million won through the Korea Credit Guarantee Fund’s Innovative Startup Support Program.
Investment option guarantees are investment-loan complex financial products designed to provide smooth funding and improve financial structure for early-stage start-ups with excellent future growth potential.
HME Healthcare is currently comprised of two founders with doctoral degrees from the University of Hong Kong and three researchers, and is focusing on the development of artificial intelligence-based antibiotic-resistant bacterial infection prediction and the discovery and development of natural products derived from egg culture microorganisms based on microbiome big data analysis, a core technology. .
Taejin Park, CEO of HME Healthcare, said, “Based on our core technology, we are accelerating the development of innovative solutions for infection diagnosis and treatment,” adding, “We are working with research institutes in various fields such as medicine, livestock, marine, fermented foods, and the environment. “We are smoothly expanding our microbiome next-generation sequencing service business,” he said.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Val